Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Focal Therapy in the Treatment of Patients With 1-3 Brain Metastases

NCT00983359 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT00983359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00983359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Focal Therapy in the Treatment of Patients With 1-3 Brain Metastases
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2007
Completion date
August 31, 2012
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, unspecified adult solid tumor, protocol specific